Yoshiaki Inoue Selected Research

sivelestat

1/2020	Evaluation of appropriate indications for the use of sivelestat sodium in acute respiratory distress syndrome: a retrospective cohort study.
5/2006	A neutrophil elastase inhibitor, sivelestat, improves leukocyte deformability in patients with acute lung injury.
8/2005	Protective effects of a selective neutrophil elastase inhibitor (sivelestat) on lipopolysaccharide-induced acute dysfunction of the pulmonary microcirculation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiaki Inoue Research Topics

Disease

14	Sepsis (Septicemia) 06/2022 - 12/2005
6	Neoplasms (Cancer) 11/2021 - 08/2003
5	Delirium 11/2022 - 01/2018
5	Disseminated Intravascular Coagulation 03/2021 - 04/2013
5	Acute Lung Injury 12/2016 - 08/2005
4	Heart Arrest (Cardiac Arrest) 04/2023 - 02/2007
4	Burns 01/2023 - 12/2005
4	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023 - 01/2020
3	Lung Injury 03/2023 - 05/2006
3	Wounds and Injuries (Trauma) 01/2023 - 04/2010
3	COVID-19 01/2022 - 03/2021
3	Neoplasm Metastasis (Metastasis) 05/2019 - 03/2010
2	Critical Illness (Critically Ill) 01/2023 - 01/2020
2	Brain Injuries (Brain Injury) 11/2022 - 08/2004
2	Inflammation (Inflammations) 06/2022 - 03/2021
2	Dyspnea (Shortness of Breath) 01/2022 - 03/2010
2	Seizures (Absence Seizure) 05/2021 - 01/2020
2	Cardiac Arrhythmias (Arrythmia) 05/2021 - 01/2020
2	Multiple Organ Failure (MODS) 03/2021 - 05/2006
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2021 - 01/2020
2	Tachycardia (Tachyarrhythmias) 01/2020 - 06/2007
2	Poisoning 01/2020 - 09/2016
2	Atrial Fibrillation 01/2020 - 08/2009
2	Body Weight (Weight, Body) 08/2017 - 02/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 03/2010
2	Hemorrhage 12/2013 - 04/2013
2	Disease Progression 03/2010 - 12/2005
2	Schizophrenia (Dementia Praecox) 04/2009 - 03/2009
1	Coma (Comas) 11/2022
1	Urticaria (Hives) 01/2022
1	Livedo Reticularis 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Elbow Injuries 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Hypotension (Low Blood Pressure) 05/2021
1	Thrombosis (Thrombus) 03/2021
1	Adenocarcinoma 10/2020
1	Adenocarcinoma of Lung 10/2020
1	Congenital Heart Defects (Congenital Heart Defect) 10/2020
1	Down Syndrome (Down's Syndrome) 10/2020

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2015
4	fosphenytoin (Cerebyx)FDA LinkGeneric 01/2023 - 01/2020
4	Dacarbazine (DIC)FDA LinkGeneric 03/2021 - 04/2013
3	Diazepam (Valium)FDA LinkGeneric 01/2023 - 01/2020
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2023 - 01/2020
3	Midazolam (Versed)FDA LinkGeneric 11/2022 - 10/2020
3	Secretory Proteinase Inhibitory ProteinsIBA 01/2020 - 08/2005
3	sivelestatIBA 01/2020 - 08/2005
2	ConnectinIBA 01/2023 - 03/2021
2	Dexmedetomidine FDA Link 11/2022 - 11/2021
2	LipopolysaccharidesIBA 06/2022 - 08/2005
2	Hypnotics and Sedatives (Sedatives)IBA 11/2021 - 10/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 01/2020
2	landiololIBA 01/2020 - 12/2016
2	SodiumIBA 01/2020 - 01/2020
2	ElementsIBA 01/2017 - 12/2005
2	Adenosine Triphosphate (ATP)IBA 12/2016 - 08/2014
2	ThrombomodulinIBA 03/2015 - 04/2013
2	Oxygen (Dioxygen)IBA 01/2015 - 08/2005
2	Purinergic P2Y2 ReceptorsIBA 06/2010 - 08/2008
2	XenonIBA 02/2007 - 12/2005
1	Colloids (Colloid)IBA 01/2023
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2022
1	NeuropeptidesIBA 06/2022
1	OrexinsIBA 06/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Interferon Type IIBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 11/2021
1	beta-hydroxyisovaleric acid (beta-hydroxy-beta-methylbutyrate)IBA 03/2021
1	alectinibIBA 10/2020
1	Anaplastic Lymphoma KinaseIBA 10/2020
1	BenzodiazepinesIBA 10/2020

Therapy/Procedure

11	Therapeutics 11/2021 - 07/2003
5	Artificial Respiration (Mechanical Ventilation) 01/2023 - 07/2019
5	Length of Stay 11/2021 - 01/2018
4	Resuscitation 01/2020 - 09/2008
4	Punctures 08/2014 - 08/2008
4	Ligation 08/2014 - 08/2008
3	Mechanical Ventilators (Ventilator) 01/2023 - 04/2013
3	Critical Care (Surgical Intensive Care) 07/2019 - 12/2013
2	Cardiopulmonary Resuscitation (CPR) 04/2023 - 02/2018
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2023 - 01/2014
2	Negative-Pressure Wound Therapy 01/2023 - 01/2022
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 11/2022 - 01/2018
2	Emergency Treatment 10/2020 - 01/2020
2	Aftercare (After-Treatment) 01/2015 - 07/2003
2	Catheter Ablation 08/2009 - 06/2007
2	Microspheres (Microsphere) 05/2005 - 08/2003
1	Deep Sedation 01/2023
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2023
1	Decompression 01/2022
1	Transplantation 01/2022
1	Free Tissue Flaps 01/2022
1	Compressed Air 01/2022
1	Perioperative Period 01/2022
1	Drug Therapy (Chemotherapy) 11/2021
1	Anesthesia 10/2020
1	Extracorporeal Membrane Oxygenation 10/2020